Trace Amount Disclosure

Trace Amount Disclosure is a scholarly contribution that specifies the minimal presence of active ingredients in a given context, distinguished by its focus on the identification and reporting of negligible or residual quantities that may influence efficacy, safety, or regulatory compliance.

1

Publications

11

Citations

9

Authors

3

Institutions

Publications per year

2017–2026

1

Authors

9

  1. DD
    Dobrislav Dobrev

    Federal Reserve Board of Governors, United States

    1 publications · 11 citations

    1

    h-index

  2. FM
    Frank M. Keane

    Federal Reserve Bank of New York, United States

    1 publications · 11 citations

    1

    h-index

  3. DB
    Doug Brain

    Federal Reserve Board of Governors, United States

    1 publications · 11 citations

    1

    h-index

  4. MP
    Michael Puglia

    Federal Reserve, United States

    1 publications · 11 citations

    1

    h-index

  5. OS
    Or Shachar

    Federal Reserve Bank of New York, United States

    1 publications · 11 citations

    1

    h-index

1–5 of 9

Institutions

3

  1. Federal Reserve

    Washington D.C., United States

    1 h-index

    3 publications

    33 citations

  2. Federal Reserve Board of Governors

    Washington D.C., United States

    1 h-index

    3 publications

    33 citations

  3. Federal Reserve Bank of New York

    New York, United States

    1 h-index

    1 publications

    11 citations

1–3 of 3

Venues

  1. FEDS Notes

    1 publications · 11 citations

    1

    h-index

1–1